Bruker Corporation designs and manufactures life science and materials research systems and associated products worldwide. Its BioScience segment offers advanced instrumentation and automated solutions based on X-ray technology, OES-spark technology, mass spectrometry technology, and infrared and Raman molecular spectroscopy technologies. It offers x-ray systems, computer-controlled positioning systems, sample handling devices, and data collection and analysis software to acquire, analyze, and manage elemental and molecular information. This segment also provides mass spectrometers that measure the mass or weight of molecules, as well as offers mass spectrometry systems and integrated solutions for applications in life-science markets, including genomics, expression proteomics, clinical proteomics, metabolic and peptide biomarker profiling, drug discovery and development, molecular diagnostics research, molecular and systems biology, and basic molecular medicine research. In addition, it offers instruments for life science, pharmaceutical analysis, and food and agricultural analysis in research and development, quality control, and process analysis applications. The company's BioSpin offers life science analysis instruments based on magnetic resonance, a natural phenomenon occurring when a molecule gives off a signature radio frequency. It develops superconducting wire materials used in various applications, including power cables, motors, generators, and superconducting magnets. Bruker Corporation serves pharmaceutical, biotechnology, proteomics and molecular diagnostic, semiconductor, chemical, cement, metals and petroleum, food, beverage, and agricultural companies, as well as academic institutions, government agencies, and raw material manufacturers. The company was formerly known as Bruker BioSciences Corporation and changed its name to Bruker Corporation in February 2008. Bruker Corporation was founded in 1991 and is headquartered in Billerica, Massachusetts.

Since 1980, the Bruker Daltonics Corporation has developed as part of the global Bruker organization. The company roots were the German Bruker-Franzen Analytik GmbH and the Swiss Spectrospin AG. These companies developed mobile detectors, as well as mass spectrometers for physical chemistry. From 1990 on, the Daltonics business received new momentum: Technological innovation now allowed the analysis of fragile biomolecules. This development opened up new markets, which have been the major driving force for growth and global expansion of Bruker Daltonics through the last decade. Since 2003, Bruker Biosciences is a publicly listed company (NasdaqNM:BRKR).

Caliper Life Sciences, Inc. develops and sells products and services to pharmaceutical and biotechnology companies, and government and other not-for-profit research institutions worldwide. Its integrated systems consist of instruments, software and reagents, laboratory automation tools, and assay and discovery services. The company offers a portfolio of molecular imaging, microfluidics, automation and liquid handling technologies, and scientific applications to address various limitations in the drug discovery and development process. Its products include IVIS Imaging Systems and Living Image Software, an integrated optical molecular imaging solution; Light-Producing Cells and Microorganisms to analyze the spread and treatment of cancer and infectious diseases, as well as to study immunology; Light Producing Transgenic Animal models to analyze gene expression, protein activity, and disease progression; and luciferin, a chemical compound to produce bioluminescence, and VivoFluor fluorescent labeling kits for fluorescent imaging. The company's products also comprise LabChip 3000 Drug Discovery System, which produces data that minimizes false positives and false negatives, and detects weak inhibitors; LabChip EZ Reader, EZ Reader II, and ProfilerPro Kits; Caliper Sciclone that incorporates automated microplate carriers; Zephyr, a liquid handling instrument; staccato automated workstations for drug discovery, genomics, proteomics, and drug development laboratories; Twister I and II, which automate the movement of microplates; MultiDose G3, an automated dissolution testing system; and active pharmaceutical ingredient workstation. In addition, it offers contract research and transgenic animal services, drug discovery and development services, product support, and validation services. Caliper Life Sciences sells its products through direct sales force and a network of distributors. The company was founded in 1995 and is headquartered in Hopkinton, Massachusetts.

Cambridge Research & Instrumentation (CRi) develops and markets optical imaging systems to advance biomedical research and molecular-based drug and diagnostic development. CRi’s patented systems enable researchers and clinicians to quantitate multiple disease and drug response markers in intact tissue samples, at a cellular level or in living small animals. CRi’s products integrate a unique multispectral imaging technology with proprietary image analysis algorithms to achieve unparalleled accuracy and sensitivity, rapidly and cost-effectively. CRi’s award-winning systems include Nuance™ for multispectral imaging on brightfield and fluorescence microscopes; inForm™ automated image analysis software; Vectra™ for high-throughput slide imaging and analysis; and Maestro™ for in-vivo optical imaging.

Camtek Ltd. engages in the design, development, manufacture, and marketing of automated optical inspection (AOI) systems and related products. Its AOI systems are computerized systems, which optically inspect various types of electronic product components for defects caused during the manufacturing process. The company's products include Dragon systems for the inspection of various printed circuit board (PCB) types in a mass production environment; Orion systems that are AOI systems for the high volume inspection of various PCB types; and the Pegasus line, which includes systems for automated inspection of finished integrated circuit (IC) substrates that are subsequently used in packaging of ball grid array and chip scale package devices. It also offers the Mustang line that includes systems for automated inspection of finished HD panels that are subsequently used in mobile consumer electronics, such as mobile-phones, digital cameras, PDAs, and other consumer electronic devices; Planet for the inspection of ultra-fine-line IC substrate; LAM for main-stream Large Area Masks (LAM) inspection; and Automated Inspectify Center, which integrates inspection and verification into one cell. In addition, Camtek provides verification systems that enable verification of panels after inspection; and the Falcon's advanced algorithms and inspection capabilities, which enable its dedicated models to detect defects in the semiconductor die. The company primarily serves the PCB, IC substrate, and semiconductor manufacturing and packaging industries. It offers its products primarily through a distribution network in the Asia Pacific region, North America, and Europe. The company was founded in 1987 and is headquartered in Migdal Ha'Emek, Israel. Camtek Ltd. operates as a subsidiary of Prior-Tech Ltd.

CANBERRA, an AREVA Company, is the worldwide leader in nuclear measurements. With over 40 years of experience in this field, Canberra bring solutions to customers, not just products or services. Wherever you are, the CANBERRA presence is not far away. CANBERRA operates a total of 12 production and engineering facilities in the United States, France, Benelux, England, and Canada. This worldwide presence also means worldwide technologies. CANBERRA has deep, long-standing relationships with the major technology centers and research laboratories around the globe. This rich diversity of technologies and personnel helps Canberra offer a broad range of best available technologies - tailored to local needs and regulations. In addition, sales and service capability exists in virtually every country of the globe. Our 1000+ employees all operate with a single focus - to bring the very best nuclear technology in the world to your operation.

Celera Corporation delivers personalized disease management through a combination of products and services. It operates in three segments: Lab Services, Products, and Corporate. The Lab Services segment offers clinical laboratory tests and disease management services for healthcare providers to enhance cardiovascular disease treatment regimens for patients. It offers clinical laboratory testing services that characterize and monitor cardiovascular disease risk, and personalized treatment and ongoing therapeutic compliance education services. The principal tests offered by this segment include LDL-S3GGE test that measures low-density lipoprotein (LDL) size as a subclass distribution divided in seven regions and characterizes the amount of LDL distributed in these regions; HDL-S10GGE test that measures high-density lipoprotein (HDL) size as a subclass distribution divided across five HDL regions and characterizes the amount of HDL distributed in these regions; Apolipoprotein E Genotypes test for lipoprotein metabolism; and Kinesin-Like Protein 6 test, which detects a variant in a gene called Kinesin-Like Protein 6. The Products segment develops and manufactures molecular diagnostic products for disease detection, prediction of disease predisposition, monitoring of disease progression and disease severity, and determination of patient responsiveness to treatments. It has a strategic alliance with Abbott Laboratories to discover, develop, and commercialize molecular diagnostic products for disease detection, prediction of disease predisposition, disease progression monitoring, and therapy selection. The Corporate segment licenses small molecule drug development programs and Life Technologies intellectual property to third parties for use in the diagnostic field; and establishes collaborations to develop cancer therapies based on its proteomics discoveries. The company was founded in 1998 and is headquartered in Alameda, California.

CEM is a company based on innovation that touches many different industries and scientific disciplines. CEM helped pioneer the field of microwave chemistry and have long been recognized for expertise on the subject through publications and awards. For more than 30 years, CEM have been designing and developing laboratory instruments and scientific methods (both microwave-based and non-microwave technologies) that are used by major companies, prestigious research institutes, and universities around the world.

Cepheid, a molecular diagnostics company, develops, manufactures, and markets integrated systems for genetic testing in the clinical molecular diagnostic, industrial, and biothreat markets. Its systems enable molecular testing for organisms and genetic-based diseases by automation. Its SmartCycler system integrates DNA amplification and detection to allow rapid analysis of a sample; and GeneXpert system integrates sample preparation in addition to DNA amplification and detection. GeneXpert is designed for reference laboratories, hospital central laboratories, and satellite testing locations, such as ER and ICU units within hospitals, and doctors offices. In the clinical molecular diagnostic market, Cepheid markets tests for both the GeneXpert and the SmartCycler platforms in the areas of hospital acquired infections, critical infectious disease, immuno-compromised transplantation, women's health, and oncology. These tests include Food and Drug Administration cleared products, such as in-vitro medical devices, CE Marked, analyte specific reagents, and research use only tests. In the industrial market, the company sells its SmartCycler along with general use polymerase chain reaction reagents and reaction tubes. Cepheid has tests available for anthrax, pestis, and tullarensis in the biothreat market. The company sells its products through direct sales and distribution channels worldwide. It has strategic relationship with bioMerieux, Inc. for bioMerieux to develop DNA testing products using nucleic acid sequence-based amplification technology. The company was founded in 1996 and is headquartered in Sunnyvale, California.

Cognex Corporation provides machine vision products primarily in the United States, Japan, and Europe. Its machine vision products capture and analyze visual information used to automate tasks primarily in manufacturing processes, where vision is required. The company operates in two divisions, Modular Vision Systems and Surface Inspection Systems. The Modular Vision Systems division develops, manufactures, and markets modular vision systems that are used to automate the manufacture of discrete items, such as cellular phones, aspirin bottles, and automobile wheels, by locating, identifying, inspecting, and measuring them during the manufacturing process. The Surface Inspection Systems division develops, manufactures, and markets surface inspection vision systems that are used to inspect the surfaces of materials processed in a continuous fashion, such as metals, paper, non-wovens, plastics, and glass. The company serves discrete factory automation, semiconductor and electronics capital equipment, and surface inspection markets. It sells its products through direct sales force and a network of integration and distribution partners. The company was founded in 1981 and is headquartered in Natick, Massachusetts.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.